Newsroom

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive Phase III results from the lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant endocrine treatment for people with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, early-stage breast cancer. The study met its primary endpoint at a pre-planned interim analysis, showing a statistically si...

GUANGZHOU, China--(BUSINESS WIRE)--Since 2015, a public welfare initiative named after the national flower of Laos, the "Champa Blossoms" welfare project has flourished alongside China Southern Power Grid (CSG) builders in Laos. Fertile Ground for Skills and Industries In 2018, the "Champa Blossoms" Project welfare team successfully relocated 10,523 people across 14 resettlement sites and 37 villages near a hydropower station. Throughout the process, the team respected local customs and establi...

SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code: “BWLP”), the owner and operator of the world’s largest fleet of Very Large Gas Carriers (VLGCs), announces today that it will release its Q3 2025 Financial Report at approximately 07:00hrs CET/ 01:00hrs EST/ 14:00hrs SGT on 2 December 2025. In connection with this release, BW LPG will hold an Earnings Presentation with Kristian Sørensen (CEO) and Samantha Xu (CFO). The details are...

PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) ("Gold Reserve" o la "Compañía") ha anunciado hoy que su Directorio ha nombrado a Michael Johnston para el cargo de presidente del Directorio, con efecto inmediato. Johnston sucede a Robert Cohen, quien deja su cargo de presidente y director luego de haberse dedicado durante años a la Compañía. El nombramiento de Johnston fue aprobado en la asamblea ordinaria del Directorio de la Compañía, que se cel...

LONDON--(BUSINESS WIRE)--Black Hat, the cybersecurity industry’s most established and in-depth security event series, today announced Max Smeets, Co-Director, Virtual Routes; Linus Neumann, Head of Security Strategy, Security Research Labs; Joe Tidy, Cyber Correspondent, BBC; and Louise Marie Hurel, Researcher, Royal United Services Institute, as Keynote speakers for Black Hat Europe 2025. These security thought leaders will deliver transformative presentations on Wednesday, December 10 and Thu...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), ein schnell wachsendes europäisches Spezialpharmaunternehmen in der Kommerzialisierungsphase, das sich auf seltene Krankheiten konzentriert, gab heute eine Wachstumsinvestition in Höhe von 32 Millionen Euro aus der Serie A von MVM Partners (MVM), einer weltweit führenden Private-Equity-Gesellschaft im Bereich Life Sciences, bekannt. Die Ankündigung folgt auf ein Rekordquartal für Avanzanite im dritten Quartal 2025, in dem sich...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Secures €32M Series A Investment from MVM Partners, setting new standard for orphan medicine launches & patient access - no one left behind...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), azienda farmaceutica specializzata europea in rapida crescita, focalizzata sulle malattie rare, ha annunciato oggi un investimento di Serie A da 32 milioni di euro da parte di MVM Partners (MVM), una delle principali società di private equity mondiali nel settore delle scienze biologiche. L'annuncio fa seguito a un terzo trimestre del 2025 da record per Avanzanite, con un fatturato triplicato rispetto all'anno precedente e in...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), een snelgroeiend Europees farmaceutisch bedrijf in de commerciële fase dat zich richt op zeldzame ziekten, heeft vandaag een Serie A-groei-investering van € 32 miljoen aangekondigd van MVM Partners (MVM), een toonaangevende wereldwijde private-equityfirma in de life sciences. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst i...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), société pharmaceutique européenne spécialisée dans les maladies rares en pleine croissance commerciale, annonce ce jour une levée de série A de 32 millions d'euros réalisée auprès de MVM Partners (MVM), un leader mondial de capital-investissement dans le domaine des sciences de la vie. Cette annonce fait suite à un troisième trimestre 2025 record pour Avanzanite, dont le chiffre d'affaires a triplé par rapport à l'année précéd...